DecisionDx-CMSeq is a 3-gene test that uses next-generation sequencing (NGS) to identify somatic mutations relevant to cutaneous melanoma in melanoma tumor tissue. The test includes hotspot mutations in the genes BRAF, NRAS and KIT.

Cancer:

Cutaneous Melanoma

Gene:

BRAF (B-raf proto-oncogene), KIT (KIT proto-oncogene, receptor tyrosine kinase), NRAS (Neuroblastoma RAS viral oncogene homolog)

Method:

Next-Generation Sequencing (NGS)

TEST:DecisionDx®-CMSeq

Details

TEST:
DecisionDx®-CMSeq